文献速递产科母胎医学

妊娠期糖尿病女性是否应在分娩住院期间筛查2型糖尿病?

Should women with gestational diabetes be screened at delivery hospitalization for type 2 diabetes?
PubMed 文献 · Am J Obstet Gynecol · 2019-07-24

该研究合并分析4个中心(6个临床站点)的患者数据,比较分娩住院期间(PP1)与产后4–12周(PP2)行75g口服葡萄糖耐量试验诊断2型糖尿病的效能。319名女性完成PP1筛查,152名(47.6%)PP2失访;PP1结果正常者(n=73)无一在PP2诊断为2型糖尿病。结论认为分娩住院期间OGTT正常似乎可排除产后2型糖尿病,但纳入空腹血糖受损或糖耐量受损时结果不一。

要点

  • 分娩住院期间OGTT正常者(n=73)在产后4–12周无一诊断为2型糖尿病。
  • PP1 OGTT诊断2型糖尿病的灵敏度50%(11.8-88.2),特异度95.7%(91.3-98.2)。
  • PP1正常(排除IFG/IGT)对PP2 2型糖尿病的阴性预测值100%(95%CI 93.5-100)。

核心结论

  • 分娩住院期间OGTT正常似乎可排除产后2型糖尿病,但纳入空腹血糖受损或糖耐量受损时结果不一。
  • 由于多数女性不返回进行产后糖尿病筛查,分娩住院期间OGTT在产后随访困难且资源可集中于分娩住院后立即筛查异常女性的特定情况下可能有用。

研究设计与样本

  • 对4个中心(6个临床站点)的患者水平数据进行合并分析,评估分娩住院期间立即行75g OGTT(PP1)与常规产后4–12周75g OGTT(PP2)诊断2型糖尿病的效用。
  • 合格女性在PP1和PP2均接受75g OGTT,估计PP1诊断2型糖尿病、空腹血糖受损或糖耐量受损的灵敏度、特异度、阴性预测值和阳性预测值。
  • 共319名女性完成PP1筛查,其中152名(47.6%)PP2 OGTT失访。

主要发现

  • PP1 OGTT正常者(n=73)无一在PP2诊断为2型糖尿病。
  • 总体12.6%的受试者(n=21)从正常变为空腹血糖受损/糖耐量受损,或从空腹血糖受损/糖耐量受损变为2型糖尿病。
  • PP1 OGTT诊断2型糖尿病 vs 正常/空腹血糖受损/糖耐量受损的灵敏度50%(11.8-88.2),特异度95.7%(91.3-98.2%),阴性预测值98.1%(94.5-99.6%),阳性预测值30%(95%CI 6.7-65.3)。
  • PP1 OGTT正常(排除空腹血糖受损/糖耐量受损)对PP2 2型糖尿病的阴性预测值100%(95%CI 93.5-100),特异度96.5%(95%CI 87.9-99.6)。

临床怎么用

  • 原文结论认为分娩住院期间OGTT正常似乎可排除产后2型糖尿病。
  • 原文指出在产后随访困难且资源可集中于分娩住院后立即筛查异常女性的特定情况下,分娩住院期间OGTT可能有用。

局限性

  • 319名完成PP1筛查的女性中152名(47.6%)PP2 OGTT失访。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Less than one-half of women with gestational diabetes mellitus are screened for type 2 diabetes postpartum. Other approaches to postpartum screening need to be evaluated, including the role of screening during the delivery hospitalization. OBJECTIVE: To assess the performance of an oral glucose tolerance test administered during the delivery hospitalization compared with the oral glucose tolerance test administered at a 4- to 12-week postpartum visit. STUDY DESIGN: We conducted a combined analysis of patient-level data from 4 centers (6 clinical sites) assessing the utility of an immediate postpartum 75-g oral glucose tolerance test during the delivery hospitalization (PP1) for the diagnosis of type 2 diabetes compared with a routine 4- to 12-week postpartum oral glucose tolerance test (PP2). Eligible women underwent a 75-g oral glucose tolerance test at both PP1 and PP2. Sensitivity, specificity, and negative and positive predictive values of the PP1 test were estimated for diagnosis of type 2 diabetes, impaired fasting glucose, or impaired glucose tolerance. RESULTS: In total, 319 women completed a PP1 screening, with 152 (47.6%) lost to follow-up for the PP2 oral glucose tolerance test. None of the women with a normal PP1 oral glucose tolerance test (n=73) later tested as having type 2 diabetes at PP2. Overall, 12.6% of subjects (n=21) had a change from normal to impaired fasting glucose/impaired glucose tolerance or a change from impaired fasting glucose/impaired glucose tolerance to type 2 diabetes. The PP1 oral glucose tolerance test had 50% sensitivity (11.8-88.2), 95.7% specificity (91.3-98.2%) with a 98.1% (94.5-99.6%) negative predictive value and a 30% (95% confidence interval, 6.7-65.3) positive predictive value for type 2 diabetes vs normal/impaired fasting glucose/impaired glucose tolerance result. The negative predictive value of having type 2 diabetes at PP2 compared with a normal oral glucose tolerance test (excluding impaired fasting glucose/impaired glucose tolerance) at PP1 was 100% (95% confidence interval, 93.5-100) with a specificity of 96.5% (95% confidence interval, 87.9-99.6). CONCLUSION: A normal oral glucose tolerance test during the delivery hospitalization appears to exclude postpartum type 2 diabetes mellitus. However, the results of the immediate postpartum oral glucose tolerance test were mixed when including impaired fasting glucose or impaired glucose tolerance. As a majority of women do not return for postpartum diabetic screening, an oral glucose tolerance test during the delivery hospitalization may be of use in certain circumstances in which postpartum follow-up is challenging and resources could be focused on women with an abnormal screening immediately after the delivery hospitalization.

来源:Am J Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Waters TP, Kim SY, Werner E, et al. Should women with gestational diabetes be screened at delivery hospitalization for type 2 diabetes? Am J Obstet Gynecol. 2019. PMID: 31351065. doi:10.1016/j.ajog.2019.07.035

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。